Adirondack Trust Co. Sells 305 Shares of Colgate-Palmolive (NYSE:CL)

Adirondack Trust Co. cut its position in Colgate-Palmolive (NYSE:CLFree Report) by 2.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,914 shares of the company’s stock after selling 305 shares during the quarter. Adirondack Trust Co.’s holdings in Colgate-Palmolive were worth $1,204,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of Colgate-Palmolive by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock valued at $6,368,378,000 after purchasing an additional 416,853 shares during the period. Price T Rowe Associates Inc. MD increased its stake in Colgate-Palmolive by 16.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 32,133,218 shares of the company’s stock worth $2,561,340,000 after acquiring an additional 4,625,472 shares during the last quarter. Morgan Stanley increased its stake in Colgate-Palmolive by 3.2% in the 3rd quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock worth $1,195,785,000 after acquiring an additional 514,559 shares during the last quarter. Northern Trust Corp increased its stake in Colgate-Palmolive by 3.3% in the 3rd quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock worth $672,198,000 after acquiring an additional 305,862 shares during the last quarter. Finally, Norges Bank bought a new position in Colgate-Palmolive in the 4th quarter worth about $731,843,000. 80.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Wells Fargo & Company upped their target price on Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a research note on Monday, April 29th. Royal Bank of Canada upped their price objective on Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a report on Monday, April 29th. The Goldman Sachs Group initiated coverage on Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 price objective for the company. Argus upped their price objective on Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a report on Wednesday, May 15th. Finally, Citigroup upped their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. Three equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.94.

Get Our Latest Stock Report on CL

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares in the company, valued at approximately $297,328.07. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The disclosure for this sale can be found here. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Stock Up 0.6 %

Shares of NYSE:CL traded up $0.54 during trading on Tuesday, hitting $96.49. The stock had a trading volume of 894,369 shares, compared to its average volume of 4,413,049. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $96.49. The company has a market capitalization of $79.16 billion, a PE ratio of 30.36, a PEG ratio of 3.48 and a beta of 0.39. The firm’s fifty day moving average is $91.86 and its 200 day moving average is $86.39. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same quarter last year, the company earned $0.73 EPS. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. Analysts anticipate that Colgate-Palmolive will post 3.53 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.